Shuttle Pharmaceuticals Files 8-K
Ticker: SHPH · Form: 8-K · Filed: Oct 29, 2024 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Oct 29, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Disclosure
TL;DR
Shuttle Pharma filed a standard 8-K, no major news.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on October 29, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates routine corporate reporting by Shuttle Pharmaceuticals Holdings, Inc. to the SEC.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not disclose any new material events or financial information that would indicate increased risk.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- October 29, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to file Financial Statements and Exhibits.
What is the exact name of the registrant?
The exact name of the registrant is Shuttle Pharmaceuticals Holdings, Inc.
In which state was Shuttle Pharmaceuticals Holdings, Inc. incorporated?
Shuttle Pharmaceuticals Holdings, Inc. was incorporated in Delaware.
What is the address of the principal executive offices?
The address of the principal executive offices is 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the telephone number of the registrant?
The registrant's telephone number, including area code, is (240) 430-4212.
Filing Stats: 885 words · 4 min read · ~3 pages · Grade level 12.3 · Accepted 2024-10-29 09:00:26
Key Financial Figures
- $0.00001 — ange on which registered Common Stock $0.00001 per share SHPH The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 12KB
- 0001493152-24-042786.txt ( ) — 233KB
- shph-20241029.xsd (EX-101.SCH) — 3KB
- shph-20241029_lab.xml (EX-101.LAB) — 33KB
- shph-20241029_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Dated: October 29, 2024 By: /s/ Anatoly Dritschilo Name: Anatoly Dritschilo Title: Chief Executive Officer